Clinical Trials Directory

Trials / Completed

CompletedNCT05386069

Does a Non-Opioid Multimodal Pain (NOMO) Protocol Decrease Narcotic Use

The Effect of a Non-Opioid Multimodal Pain (NOMO) Protocol in Decreasing Narcotic Use After Urogynecologic Surgery

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Prisma Health-Upstate · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

The objective of this study is to evaluate narcotic use after implementation of a Non-Opioid Multimodal Pain (NOMO) protocol in patients who are undergoing a urogynecologic procedure. The study will also evaluate secondary outcomes, including: post-operative pain rating, length of hospital stay, postoperative antiemetic use, bladder catheterization at discharge, number of post-operative phone calls, and rate of reported side effects of opioid use (nausea/constipation). Study participants will be asked to utilize the validated Brief Pain Inventory (appendix A) scale to assess post-operative pain levels. Based on inpatient post-operative opioid use and number of opioid pills prescribed at discharge, an attempt will be made to develop an algorithm for recommended opioid prescribing patterns.

Detailed description

The objective of this study is to evaluate narcotic use after implementation of a Non-Opioid Multimodal Pain (NOMO) protocol in patients who are undergoing a urogynecologic procedure. NOMO protocols seek to reduce the opioid usage for patients in the postoperative period. Patients will receive multiple pain medications (usually referred to as a "pain cocktail") that work on various pain receptors throughout the body. These medications are approved for pain control; but they have few side effects and less addictive properties. The study will also evaluate secondary outcomes, including: post-operative pain rating, length of hospital stay, postoperative antiemetic use, bladder catheterization at discharge, number of post-operative phone calls, and rate of reported side effects of opioid use (nausea/constipation). Study participants will be asked to utilize the validated Brief Pain Inventory (appendix A) scale to assess post-operative pain levels. Based on inpatient post-operative opioid use and number of opioid pills prescribed at discharge, an attempt will be made to develop an algorithm for recommended opioid prescribing patterns.

Conditions

Interventions

TypeNameDescription
DRUGNOMO ProtocolStandard weight-based ketamine bolus (0.5 mg/kg) at procedure start, no Opioid rescue medications

Timeline

Start date
2019-11-15
Primary completion
2020-12-01
Completion
2021-06-01
First posted
2022-05-23
Last updated
2025-05-23
Results posted
2025-05-23

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05386069. Inclusion in this directory is not an endorsement.

Does a Non-Opioid Multimodal Pain (NOMO) Protocol Decrease Narcotic Use (NCT05386069) · Clinical Trials Directory